Key result
Medicinal plants offer potential complementary cardiovascular benefits, but clinical safety and efficacy remain unproven.
Answers are grounded in this paper and cite their sources.
Review reveals therapeutic benefits and safety concerns of herbal medicines in cardiovascular disease, highlighting the need for clinical risk evaluation.
Many cultivated and wild plants are used for the management of various diseases, specifically renal and hepatic diseases and those of the immune and cardiovascular systems. In China, medicinal plants from ancient to modern history have been used in patients with angina pectoris, congestive heart failure (CHF), systolic hypertension, arrhythmia, and venous insufficiency for centuries. The latest increase in the fame of natural products and alternative medicine has revived interest in conventional remedies that have been consumed in the management of CVD. The cardio-protective properties of the various herbs are possibly due to their anti-oxidative, antihypercholesterolemic, anti-ischemic activities, and inhibition of platelet aggregation that reduce the risk of CVD. Ethno-pharmacological and biological properties of these plants are explored, based upon published scientific literature. Although a majority of medicinal plants having a biological mechanism that linked with CVD management, to date, published literature pertaining to their promising scientific properties are still poorly understood. Compared with synthetic medicines, alternative medicines do not need scientific studies before their formal approval from the government sector and due to this purpose; their safety, as well as efficacy, still remain elusive. Taken together, we addressed all accessible evidence on alternative medicines commonly consumed in CVD management. Our comprehensive analysis of the scientific literature indicated that many TCMs are available and valuable herbal medication would be the best alternative for the management of CVD as a complementary therapy. Furthermore, practitioners should always discuss possible benefits-risks of alternative medicines with patients so that they are aware of the consumption of alternative medications.
No takes yet. Share an insight, caveat, or question.
Naveed et al. (2020) conducted a review in Cardiovascular disorders (angina pectoris, congestive heart failure, systolic hypertension, arrhythmia, and venous insufficiency). Medicinal plants and traditional Chinese medicines vs. Synthetic medicines was evaluated. Medicinal plants and traditional Chinese medicines may serve as complementary therapies for cardiovascular disorders, though their clinical safety and efficacy remain poorly understood.
Synapse has enriched 10 related papers. Consider them for comparative context: